NoticeThis is an independent non-profit initiative. We are not affiliated with the European Medicines Agency (EMA) or the official CTIS system. For the official EU Clinical Trials Information System, visit:
EMA Registry →
metastatic colorectal cancer with a proven
RAS mutation after failure of standard systemic treatment regimens including at least 5-
FU/capecitabine-oxaliplatin and irinotecan based standard treatment (unless contra-indications
for either oxaliplatin or irinotecan)
1 total trials
Filter these 1 trials by phase, country, sponsor and more.